

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | indole-containing compound catabolic process (GO:0042436) | 4.85066999 |
| 2 | indolalkylamine catabolic process (GO:0046218) | 4.85066999 |
| 3 | tryptophan catabolic process (GO:0006569) | 4.85066999 |
| 4 | indolalkylamine metabolic process (GO:0006586) | 4.61560503 |
| 5 | kynurenine metabolic process (GO:0070189) | 4.55952911 |
| 6 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.22517810 |
| 7 | tryptophan metabolic process (GO:0006568) | 4.10108210 |
| 8 | behavioral response to nicotine (GO:0035095) | 4.09376639 |
| 9 | alanine transport (GO:0032328) | 4.01371530 |
| 10 | polyketide metabolic process (GO:0030638) | 3.97814125 |
| 11 | doxorubicin metabolic process (GO:0044598) | 3.97814125 |
| 12 | daunorubicin metabolic process (GO:0044597) | 3.97814125 |
| 13 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.97133253 |
| 14 | fucose catabolic process (GO:0019317) | 3.93127176 |
| 15 | L-fucose metabolic process (GO:0042354) | 3.93127176 |
| 16 | L-fucose catabolic process (GO:0042355) | 3.93127176 |
| 17 | regulation of hippo signaling (GO:0035330) | 3.92475572 |
| 18 | NADH metabolic process (GO:0006734) | 3.88875685 |
| 19 | carnitine shuttle (GO:0006853) | 3.83878751 |
| 20 | glycine transport (GO:0015816) | 3.64726062 |
| 21 | cell communication by electrical coupling (GO:0010644) | 3.62240037 |
| 22 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.61871335 |
| 23 | detection of light stimulus involved in visual perception (GO:0050908) | 3.61871335 |
| 24 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.55346003 |
| 25 | cellular ketone body metabolic process (GO:0046950) | 3.52942507 |
| 26 | photoreceptor cell maintenance (GO:0045494) | 3.47737182 |
| 27 | cellular potassium ion homeostasis (GO:0030007) | 3.47363403 |
| 28 | NAD biosynthetic process (GO:0009435) | 3.45993460 |
| 29 | sodium ion export (GO:0071436) | 3.45592415 |
| 30 | biotin metabolic process (GO:0006768) | 3.40011122 |
| 31 | proline transport (GO:0015824) | 3.38142094 |
| 32 | interkinetic nuclear migration (GO:0022027) | 3.37209393 |
| 33 | fatty acid transmembrane transport (GO:1902001) | 3.35064540 |
| 34 | locomotory exploration behavior (GO:0035641) | 3.33801452 |
| 35 | positive regulation of developmental pigmentation (GO:0048087) | 3.33581093 |
| 36 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.32896548 |
| 37 | regulation of pigment cell differentiation (GO:0050932) | 3.31169154 |
| 38 | indole-containing compound metabolic process (GO:0042430) | 3.31012071 |
| 39 | flavonoid metabolic process (GO:0009812) | 3.25201750 |
| 40 | cellular biogenic amine catabolic process (GO:0042402) | 3.21662301 |
| 41 | amine catabolic process (GO:0009310) | 3.21662301 |
| 42 | tricarboxylic acid cycle (GO:0006099) | 3.18604590 |
| 43 | carnitine transmembrane transport (GO:1902603) | 3.17303421 |
| 44 | drug catabolic process (GO:0042737) | 3.15681800 |
| 45 | ketone body metabolic process (GO:1902224) | 3.15155119 |
| 46 | signal peptide processing (GO:0006465) | 3.14331336 |
| 47 | snRNA transcription (GO:0009301) | 3.12959963 |
| 48 | regulation of gene silencing by RNA (GO:0060966) | 3.12695392 |
| 49 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.12695392 |
| 50 | regulation of gene silencing by miRNA (GO:0060964) | 3.12695392 |
| 51 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.12309984 |
| 52 | lysine catabolic process (GO:0006554) | 3.09808939 |
| 53 | lysine metabolic process (GO:0006553) | 3.09808939 |
| 54 | short-chain fatty acid metabolic process (GO:0046459) | 3.09533254 |
| 55 | fatty acid beta-oxidation (GO:0006635) | 3.08378137 |
| 56 | sulfation (GO:0051923) | 3.08221208 |
| 57 | potassium ion import (GO:0010107) | 3.07932494 |
| 58 | regulation of fatty acid oxidation (GO:0046320) | 3.07097331 |
| 59 | axoneme assembly (GO:0035082) | 3.05718791 |
| 60 | regulation of sarcomere organization (GO:0060297) | 3.05662459 |
| 61 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.03856342 |
| 62 | amino-acid betaine transport (GO:0015838) | 3.03081379 |
| 63 | carnitine transport (GO:0015879) | 3.03081379 |
| 64 | regulation of skeletal muscle contraction (GO:0014819) | 3.01897692 |
| 65 | auditory receptor cell stereocilium organization (GO:0060088) | 3.00908091 |
| 66 | oxidative demethylation (GO:0070989) | 3.00836651 |
| 67 | establishment of protein localization to Golgi (GO:0072600) | 2.98957223 |
| 68 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.98851795 |
| 69 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.97386536 |
| 70 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.96654277 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 2.96632461 |
| 72 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.96606948 |
| 73 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.96606948 |
| 74 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.96606948 |
| 75 | positive regulation of fatty acid oxidation (GO:0046321) | 2.94897407 |
| 76 | succinate metabolic process (GO:0006105) | 2.91466220 |
| 77 | neural tube formation (GO:0001841) | 2.90864250 |
| 78 | regulation of sequestering of triglyceride (GO:0010889) | 2.89974186 |
| 79 | reflex (GO:0060004) | 2.89670520 |
| 80 | tricarboxylic acid metabolic process (GO:0072350) | 2.89597315 |
| 81 | protein K48-linked deubiquitination (GO:0071108) | 2.87793249 |
| 82 | L-amino acid import (GO:0043092) | 2.87567495 |
| 83 | thyroid hormone metabolic process (GO:0042403) | 2.87507181 |
| 84 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.84665283 |
| 85 | striated muscle atrophy (GO:0014891) | 2.84044285 |
| 86 | cilium movement (GO:0003341) | 2.83269274 |
| 87 | synaptic vesicle maturation (GO:0016188) | 2.81937396 |
| 88 | regulation of beta-amyloid formation (GO:1902003) | 2.80068930 |
| 89 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.77286405 |
| 90 | negative regulation of mast cell activation (GO:0033004) | 2.76375036 |
| 91 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.74258276 |
| 92 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.73373019 |
| 93 | lipid oxidation (GO:0034440) | 2.73217417 |
| 94 | cellular response to ATP (GO:0071318) | 2.73047796 |
| 95 | cell communication involved in cardiac conduction (GO:0086065) | 2.72168004 |
| 96 | carnitine metabolic process (GO:0009437) | 2.71169559 |
| 97 | aspartate family amino acid catabolic process (GO:0009068) | 2.70616476 |
| 98 | primary amino compound metabolic process (GO:1901160) | 2.69656517 |
| 99 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.69252554 |
| 100 | protein K11-linked deubiquitination (GO:0035871) | 2.68525994 |
| 101 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.68145203 |
| 102 | fatty acid oxidation (GO:0019395) | 2.67365830 |
| 103 | fatty acid catabolic process (GO:0009062) | 2.66724453 |
| 104 | activation of protein kinase A activity (GO:0034199) | 2.66243771 |
| 105 | relaxation of cardiac muscle (GO:0055119) | 2.65585947 |
| 106 | protein K63-linked deubiquitination (GO:0070536) | 2.65520513 |
| 107 | serotonin metabolic process (GO:0042428) | 2.62068190 |
| 108 | alpha-linolenic acid metabolic process (GO:0036109) | 2.61392956 |
| 109 | aromatic amino acid family catabolic process (GO:0009074) | 2.61196665 |
| 110 | cholesterol catabolic process (GO:0006707) | 2.60681788 |
| 111 | sterol catabolic process (GO:0016127) | 2.60681788 |
| 112 | vocalization behavior (GO:0071625) | 2.60307545 |
| 113 | motile cilium assembly (GO:0044458) | 2.59096942 |
| 114 | rRNA catabolic process (GO:0016075) | 2.59016076 |
| 115 | epithelial cilium movement (GO:0003351) | 2.58894426 |
| 116 | 2-oxoglutarate metabolic process (GO:0006103) | 2.58592848 |
| 117 | cellular response to exogenous dsRNA (GO:0071360) | 2.58195633 |
| 118 | skeletal muscle adaptation (GO:0043501) | 2.57806032 |
| 119 | cellular response to ethanol (GO:0071361) | 2.57683395 |
| 120 | DNA deamination (GO:0045006) | 2.57511849 |
| 121 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.56871892 |
| 122 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.56230344 |
| 123 | gamma-aminobutyric acid transport (GO:0015812) | 2.55092301 |
| 124 | cAMP catabolic process (GO:0006198) | 2.54433177 |
| 125 | response to pheromone (GO:0019236) | 2.54142730 |
| 126 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.53733839 |
| 127 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.53733839 |
| 128 | potassium ion homeostasis (GO:0055075) | 2.53676407 |
| 129 | behavioral response to ethanol (GO:0048149) | 2.53581219 |
| 130 | negative regulation of protein localization to cell surface (GO:2000009) | 2.53215100 |
| 131 | fatty acid homeostasis (GO:0055089) | 2.52913216 |
| 132 | multicellular organism reproduction (GO:0032504) | 2.52502351 |
| 133 | exogenous drug catabolic process (GO:0042738) | 2.51745574 |
| 134 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.50312770 |
| 135 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.50084500 |
| 136 | retinal cone cell development (GO:0046549) | 2.49038660 |
| 137 | neuronal action potential (GO:0019228) | 2.48786288 |
| 138 | membrane depolarization during action potential (GO:0086010) | 2.48189628 |
| 139 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.48041652 |
| 140 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.47017755 |
| 141 | positive regulation of fatty acid transport (GO:2000193) | 2.46968536 |
| 142 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.46359803 |
| 143 | fructose metabolic process (GO:0006000) | 2.46123306 |
| 144 | dicarboxylic acid catabolic process (GO:0043649) | 2.45369836 |
| 145 | regulation of action potential (GO:0098900) | 2.45041113 |
| 146 | cilium organization (GO:0044782) | 2.44995133 |
| 147 | amino acid import (GO:0043090) | 2.44934887 |
| 148 | transepithelial transport (GO:0070633) | 2.44050552 |
| 149 | regulation of triglyceride catabolic process (GO:0010896) | 2.44020164 |
| 150 | valine metabolic process (GO:0006573) | 2.43856579 |
| 151 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.42341195 |
| 152 | cellular sodium ion homeostasis (GO:0006883) | 2.42057527 |
| 153 | pericardium development (GO:0060039) | 2.41084002 |
| 154 | amino-acid betaine metabolic process (GO:0006577) | 2.41010881 |
| 155 | aromatic amino acid family metabolic process (GO:0009072) | 2.40968423 |
| 156 | spinal cord motor neuron differentiation (GO:0021522) | 2.40854924 |
| 157 | quaternary ammonium group transport (GO:0015697) | 2.40580529 |
| 158 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.40562038 |
| 159 | phospholipid translocation (GO:0045332) | 2.40399607 |
| 160 | lipid translocation (GO:0034204) | 2.40399607 |
| 161 | cellular response to sterol (GO:0036315) | 2.38462390 |
| 162 | monocarboxylic acid catabolic process (GO:0072329) | 2.37686673 |
| 163 | positive regulation of glycolytic process (GO:0045821) | 2.37647054 |
| 164 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.37441567 |
| 165 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.37433802 |
| 166 | alkaloid metabolic process (GO:0009820) | 2.37311322 |
| 167 | cilium assembly (GO:0042384) | 2.36929004 |
| 168 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.36450005 |
| 169 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.36054605 |
| 170 | membrane repolarization (GO:0086009) | 2.35920303 |
| 171 | response to auditory stimulus (GO:0010996) | 2.35078108 |
| 172 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.34000604 |
| 173 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.33981406 |
| 174 | regulation of synaptic vesicle transport (GO:1902803) | 2.33202721 |
| 175 | branched-chain amino acid catabolic process (GO:0009083) | 2.32761031 |
| 176 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.32544544 |
| 177 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.32435549 |
| 178 | regulation of membrane repolarization (GO:0060306) | 2.32424165 |
| 179 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.31999247 |
| 180 | regulation of ARF protein signal transduction (GO:0032012) | 2.30617493 |
| 181 | glutamate secretion (GO:0014047) | 2.24920939 |
| 182 | neurotransmitter secretion (GO:0007269) | 2.24800471 |
| 183 | adenine nucleotide transport (GO:0051503) | 2.24296643 |
| 184 | branched-chain amino acid metabolic process (GO:0009081) | 2.23897165 |
| 185 | nucleoside diphosphate catabolic process (GO:0009134) | 2.22498590 |
| 186 | neuronal action potential propagation (GO:0019227) | 2.21031737 |
| 187 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.20239954 |
| 188 | hormone catabolic process (GO:0042447) | 2.19804906 |
| 189 | detection of calcium ion (GO:0005513) | 2.19536241 |
| 190 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.19439225 |
| 191 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.18500454 |
| 192 | acyl-CoA biosynthetic process (GO:0071616) | 2.17992595 |
| 193 | thioester biosynthetic process (GO:0035384) | 2.17992595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.50682779 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.19155870 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.02484665 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.91280673 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.47837954 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.41389534 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.22430368 |
| 8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.22223571 |
| 9 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.19239691 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.18220061 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.15953098 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.12584641 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.09846392 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.99911957 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.96896623 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.96213659 |
| 17 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.89316394 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.88018322 |
| 19 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.86979910 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.86393071 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.83446567 |
| 22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.80335600 |
| 23 | P300_19829295_ChIP-Seq_ESCs_Human | 1.79414116 |
| 24 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.78098843 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.77173460 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76677827 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.68169165 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.67982021 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.67982021 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.67683663 |
| 31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.66448158 |
| 32 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62838604 |
| 33 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.62108285 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61946925 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.61438813 |
| 36 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.59732568 |
| 37 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.58580672 |
| 38 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.57898091 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.57161958 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56478098 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51615610 |
| 42 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.51406229 |
| 43 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51386235 |
| 44 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.51386235 |
| 45 | EWS_26573619_Chip-Seq_HEK293_Human | 1.51038996 |
| 46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.50917010 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.50817485 |
| 48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.49458319 |
| 49 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47892227 |
| 50 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47892227 |
| 51 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47403905 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47173825 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.45615779 |
| 54 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40258237 |
| 55 | TP53_16413492_ChIP-PET_HCT116_Human | 1.40121196 |
| 56 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.39041478 |
| 57 | RXR_22108803_ChIP-Seq_LS180_Human | 1.37383920 |
| 58 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.35960221 |
| 59 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.35740793 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.34822068 |
| 61 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.34580330 |
| 62 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.34099089 |
| 63 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.33776838 |
| 64 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32590762 |
| 65 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.31930827 |
| 66 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31506803 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.28029397 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27174706 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25813415 |
| 70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.25635534 |
| 71 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25251768 |
| 72 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24658472 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23367356 |
| 74 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22526817 |
| 75 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.21620988 |
| 76 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.21620988 |
| 77 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21512954 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20911954 |
| 79 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.20281723 |
| 80 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20148392 |
| 81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19943993 |
| 82 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19523458 |
| 83 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19201448 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18997888 |
| 85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.18836068 |
| 86 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.18671903 |
| 87 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.18179824 |
| 88 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.17141675 |
| 89 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16614700 |
| 90 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.16009002 |
| 91 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.15725265 |
| 92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15724029 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15614386 |
| 94 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.15146647 |
| 95 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14697704 |
| 96 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13947982 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13207941 |
| 98 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12864481 |
| 99 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.12567677 |
| 100 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12145662 |
| 101 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12046885 |
| 102 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11965242 |
| 103 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11451880 |
| 104 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11099954 |
| 105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09350656 |
| 106 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09159046 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07796530 |
| 108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07745814 |
| 109 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.07043216 |
| 110 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05911983 |
| 111 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05727434 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05163880 |
| 113 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.04979384 |
| 114 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04179139 |
| 115 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03364884 |
| 116 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02473400 |
| 117 | AR_19668381_ChIP-Seq_PC3_Human | 1.01852648 |
| 118 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00981986 |
| 119 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.00943899 |
| 120 | AR_20517297_ChIP-Seq_VCAP_Human | 1.00750449 |
| 121 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.00672716 |
| 122 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.00672716 |
| 123 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.00247651 |
| 124 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00113524 |
| 125 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99419480 |
| 126 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98675609 |
| 127 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98670228 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98240214 |
| 129 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97764199 |
| 130 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97596377 |
| 131 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97272028 |
| 132 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.97139707 |
| 133 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96375480 |
| 134 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96115741 |
| 135 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95947963 |
| 136 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95286541 |
| 137 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93856825 |
| 138 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92824816 |
| 139 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91702687 |
| 140 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90421206 |
| 141 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88785095 |
| 142 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88043979 |
| 143 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87160604 |
| 144 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86046511 |
| 145 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86046511 |
| 146 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85720670 |
| 147 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85122446 |
| 148 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84876991 |
| 149 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.84849030 |
| 150 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82635093 |
| 151 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82191633 |
| 152 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81732536 |
| 153 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81351754 |
| 154 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80475102 |
| 155 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.79562125 |
| 156 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.79091053 |
| 157 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.79025411 |
| 158 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.78919459 |
| 159 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78440113 |
| 160 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.77479961 |
| 161 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76841761 |
| 162 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.76638265 |
| 163 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76067080 |
| 164 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.75984339 |
| 165 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.75188301 |
| 166 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.73922102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.20969816 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.17081979 |
| 3 | MP0004043_abnormal_pH_regulation | 3.11764802 |
| 4 | MP0009780_abnormal_chondrocyte_physiolo | 2.73802140 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 2.68704231 |
| 6 | MP0005670_abnormal_white_adipose | 2.65936079 |
| 7 | MP0003646_muscle_fatigue | 2.54853908 |
| 8 | MP0002909_abnormal_adrenal_gland | 2.49249681 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 2.39903615 |
| 10 | MP0005646_abnormal_pituitary_gland | 2.37520549 |
| 11 | MP0004130_abnormal_muscle_cell | 2.33286046 |
| 12 | MP0004145_abnormal_muscle_electrophysio | 2.28244741 |
| 13 | MP0005365_abnormal_bile_salt | 2.21637109 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.15310586 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.09398916 |
| 16 | MP0003690_abnormal_glial_cell | 2.02794343 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.02454657 |
| 18 | MP0005645_abnormal_hypothalamus_physiol | 2.00029837 |
| 19 | MP0005360_urolithiasis | 1.96660134 |
| 20 | MP0005535_abnormal_body_temperature | 1.96154684 |
| 21 | MP0004858_abnormal_nervous_system | 1.94534624 |
| 22 | MP0003868_abnormal_feces_composition | 1.91290834 |
| 23 | MP0008057_abnormal_DNA_replication | 1.91178086 |
| 24 | MP0003635_abnormal_synaptic_transmissio | 1.88482275 |
| 25 | MP0009840_abnormal_foam_cell | 1.86450664 |
| 26 | MP0005085_abnormal_gallbladder_physiolo | 1.86128062 |
| 27 | MP0008872_abnormal_physiological_respon | 1.84855910 |
| 28 | MP0000427_abnormal_hair_cycle | 1.82101077 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.80423423 |
| 30 | MP0000383_abnormal_hair_follicle | 1.80395017 |
| 31 | MP0005332_abnormal_amino_acid | 1.78266967 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.73367952 |
| 33 | MP0002971_abnormal_brown_adipose | 1.71800311 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.71567482 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.70551642 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.68333194 |
| 37 | MP0001502_abnormal_circadian_rhythm | 1.66507974 |
| 38 | MP0003950_abnormal_plasma_membrane | 1.65014507 |
| 39 | MP0001486_abnormal_startle_reflex | 1.64047804 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.61414424 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.60732541 |
| 42 | MP0004215_abnormal_myocardial_fiber | 1.59662448 |
| 43 | MP0003329_amyloid_beta_deposits | 1.58939855 |
| 44 | MP0002078_abnormal_glucose_homeostasis | 1.58571766 |
| 45 | MP0008877_abnormal_DNA_methylation | 1.57904526 |
| 46 | MP0003879_abnormal_hair_cell | 1.55093859 |
| 47 | MP0009745_abnormal_behavioral_response | 1.53439627 |
| 48 | MP0009046_muscle_twitch | 1.51326768 |
| 49 | MP0008569_lethality_at_weaning | 1.51275397 |
| 50 | MP0005253_abnormal_eye_physiology | 1.50840602 |
| 51 | MP0008775_abnormal_heart_ventricle | 1.49538333 |
| 52 | MP0001666_abnormal_nutrient_absorption | 1.49113225 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.48544876 |
| 54 | MP0002064_seizures | 1.48178021 |
| 55 | MP0002102_abnormal_ear_morphology | 1.47456553 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.44499215 |
| 57 | MP0004885_abnormal_endolymph | 1.41171619 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.41134730 |
| 59 | MP0008961_abnormal_basal_metabolism | 1.37947330 |
| 60 | MP0002736_abnormal_nociception_after | 1.37928376 |
| 61 | MP0003136_yellow_coat_color | 1.37520574 |
| 62 | MP0002877_abnormal_melanocyte_morpholog | 1.33526024 |
| 63 | MP0003252_abnormal_bile_duct | 1.33185205 |
| 64 | MP0002063_abnormal_learning/memory/cond | 1.32308774 |
| 65 | MP0002638_abnormal_pupillary_reflex | 1.32049467 |
| 66 | MP0002735_abnormal_chemical_nociception | 1.31431372 |
| 67 | MP0000538_abnormal_urinary_bladder | 1.30994046 |
| 68 | MP0002693_abnormal_pancreas_physiology | 1.29782435 |
| 69 | MP0002572_abnormal_emotion/affect_behav | 1.28887563 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 1.28363912 |
| 71 | MP0004270_analgesia | 1.27740679 |
| 72 | MP0003633_abnormal_nervous_system | 1.25672595 |
| 73 | MP0010386_abnormal_urinary_bladder | 1.25015280 |
| 74 | MP0000751_myopathy | 1.24518097 |
| 75 | MP0004142_abnormal_muscle_tone | 1.24424981 |
| 76 | MP0004484_altered_response_of | 1.23751841 |
| 77 | MP0002822_catalepsy | 1.21804698 |
| 78 | MP0005266_abnormal_metabolism | 1.19039812 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 1.18479108 |
| 80 | MP0003075_altered_response_to | 1.18458441 |
| 81 | MP0002272_abnormal_nervous_system | 1.17701265 |
| 82 | MP0002168_other_aberrant_phenotype | 1.16745470 |
| 83 | MP0005448_abnormal_energy_balance | 1.16531772 |
| 84 | MP0006276_abnormal_autonomic_nervous | 1.16296750 |
| 85 | MP0005058_abnormal_lysosome_morphology | 1.16038716 |
| 86 | MP0003953_abnormal_hormone_level | 1.15419060 |
| 87 | MP0001440_abnormal_grooming_behavior | 1.13390758 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12758246 |
| 89 | MP0005375_adipose_tissue_phenotype | 1.11710927 |
| 90 | MP0003172_abnormal_lysosome_physiology | 1.10820328 |
| 91 | MP0001765_abnormal_ion_homeostasis | 1.09802540 |
| 92 | MP0005334_abnormal_fat_pad | 1.09575562 |
| 93 | MP0006072_abnormal_retinal_apoptosis | 1.09470273 |
| 94 | MP0002067_abnormal_sensory_capabilities | 1.08162329 |
| 95 | MP0003787_abnormal_imprinting | 1.07567374 |
| 96 | MP0002734_abnormal_mechanical_nocicepti | 1.07499696 |
| 97 | MP0004085_abnormal_heartbeat | 1.05538908 |
| 98 | MP0001944_abnormal_pancreas_morphology | 1.05114685 |
| 99 | MP0005423_abnormal_somatic_nervous | 1.04967974 |
| 100 | MP0005410_abnormal_fertilization | 1.04365017 |
| 101 | MP0003137_abnormal_impulse_conducting | 1.02989909 |
| 102 | MP0003718_maternal_effect | 1.00973470 |
| 103 | MP0002653_abnormal_ependyma_morphology | 1.00553772 |
| 104 | MP0005379_endocrine/exocrine_gland_phen | 1.00421866 |
| 105 | MP0002557_abnormal_social/conspecific_i | 0.99971424 |
| 106 | MP0004133_heterotaxia | 0.99874220 |
| 107 | MP0004147_increased_porphyrin_level | 0.99253475 |
| 108 | MP0001756_abnormal_urination | 0.98871882 |
| 109 | MP0009643_abnormal_urine_homeostasis | 0.98717661 |
| 110 | MP0002332_abnormal_exercise_endurance | 0.98611889 |
| 111 | MP0005386_behavior/neurological_phenoty | 0.98406040 |
| 112 | MP0004924_abnormal_behavior | 0.98406040 |
| 113 | MP0000604_amyloidosis | 0.98044806 |
| 114 | MP0005377_hearing/vestibular/ear_phenot | 0.97861063 |
| 115 | MP0003878_abnormal_ear_physiology | 0.97861063 |
| 116 | MP0003300_gastrointestinal_ulcer | 0.97030953 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.96945213 |
| 118 | MP0005620_abnormal_muscle_contractility | 0.96674272 |
| 119 | MP0002972_abnormal_cardiac_muscle | 0.96227773 |
| 120 | MP0002254_reproductive_system_inflammat | 0.96114174 |
| 121 | MP0000609_abnormal_liver_physiology | 0.94538796 |
| 122 | MP0002229_neurodegeneration | 0.93266703 |
| 123 | MP0001984_abnormal_olfaction | 0.93243887 |
| 124 | MP0000372_irregular_coat_pigmentation | 0.93002469 |
| 125 | MP0004036_abnormal_muscle_relaxation | 0.91924380 |
| 126 | MP0001664_abnormal_digestion | 0.91452289 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.90618935 |
| 128 | MP0004084_abnormal_cardiac_muscle | 0.89898968 |
| 129 | MP0005395_other_phenotype | 0.89616198 |
| 130 | MP0003195_calcinosis | 0.88570344 |
| 131 | MP0000631_abnormal_neuroendocrine_gland | 0.88196343 |
| 132 | MP0001764_abnormal_homeostasis | 0.88122618 |
| 133 | MP0000470_abnormal_stomach_morphology | 0.87719411 |
| 134 | MP0005310_abnormal_salivary_gland | 0.86582600 |
| 135 | MP0000230_abnormal_systemic_arterial | 0.85844781 |
| 136 | MP0002160_abnormal_reproductive_system | 0.84813967 |
| 137 | MP0001485_abnormal_pinna_reflex | 0.84592775 |
| 138 | MP0003045_fibrosis | 0.84249366 |
| 139 | MP0001970_abnormal_pain_threshold | 0.84217819 |
| 140 | MP0002069_abnormal_eating/drinking_beha | 0.84120893 |
| 141 | MP0004019_abnormal_vitamin_homeostasis | 0.83943852 |
| 142 | MP0002733_abnormal_thermal_nociception | 0.83039108 |
| 143 | MP0003890_abnormal_embryonic-extraembry | 0.81939498 |
| 144 | MP0009764_decreased_sensitivity_to | 0.79084622 |
| 145 | MP0005083_abnormal_biliary_tract | 0.77678754 |
| 146 | MP0010678_abnormal_skin_adnexa | 0.77528598 |
| 147 | MP0002928_abnormal_bile_duct | 0.74927675 |
| 148 | MP0003698_abnormal_male_reproductive | 0.74493870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.92554611 |
| 2 | Ketoacidosis (HP:0001993) | 4.60548207 |
| 3 | Pancreatic cysts (HP:0001737) | 4.58857169 |
| 4 | Hyperglycinuria (HP:0003108) | 4.54474257 |
| 5 | Hyperventilation (HP:0002883) | 4.39107083 |
| 6 | Hypoglycemic seizures (HP:0002173) | 4.06901652 |
| 7 | Pancreatic fibrosis (HP:0100732) | 3.99263202 |
| 8 | True hermaphroditism (HP:0010459) | 3.76836721 |
| 9 | Ketosis (HP:0001946) | 3.76385892 |
| 10 | Hydroxyprolinuria (HP:0003080) | 3.75133352 |
| 11 | Abnormality of proline metabolism (HP:0010907) | 3.75133352 |
| 12 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.74660126 |
| 13 | Clumsiness (HP:0002312) | 3.72613746 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 3.72350719 |
| 15 | Molar tooth sign on MRI (HP:0002419) | 3.71811178 |
| 16 | Abnormality of midbrain morphology (HP:0002418) | 3.71811178 |
| 17 | Chronic hepatic failure (HP:0100626) | 3.68229258 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.64599320 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 3.64599320 |
| 20 | Myoglobinuria (HP:0002913) | 3.60402674 |
| 21 | Congenital stationary night blindness (HP:0007642) | 3.53804930 |
| 22 | Attenuation of retinal blood vessels (HP:0007843) | 3.51754708 |
| 23 | Symptomatic seizures (HP:0011145) | 3.50559176 |
| 24 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.47537802 |
| 25 | Abnormality of the renal cortex (HP:0011035) | 3.41953763 |
| 26 | Nephronophthisis (HP:0000090) | 3.41733553 |
| 27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.29737933 |
| 28 | Abnormality of the renal medulla (HP:0100957) | 3.23313440 |
| 29 | Dicarboxylic aciduria (HP:0003215) | 3.20603652 |
| 30 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.20603652 |
| 31 | Generalized aminoaciduria (HP:0002909) | 3.12664622 |
| 32 | Bundle branch block (HP:0011710) | 3.10613994 |
| 33 | Cystic liver disease (HP:0006706) | 3.10502687 |
| 34 | Hyperammonemia (HP:0001987) | 3.03036867 |
| 35 | Congenital sensorineural hearing impairment (HP:0008527) | 3.02774448 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.01160934 |
| 37 | Protruding tongue (HP:0010808) | 2.97600882 |
| 38 | Focal motor seizures (HP:0011153) | 2.96829125 |
| 39 | Tubular atrophy (HP:0000092) | 2.96075881 |
| 40 | Abnormal drinking behavior (HP:0030082) | 2.92173146 |
| 41 | Polydipsia (HP:0001959) | 2.92173146 |
| 42 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.86834290 |
| 43 | Hyperglycinemia (HP:0002154) | 2.85973686 |
| 44 | Exercise-induced myalgia (HP:0003738) | 2.83223034 |
| 45 | Abolished electroretinogram (ERG) (HP:0000550) | 2.78846890 |
| 46 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.74203445 |
| 47 | Absent/shortened dynein arms (HP:0200106) | 2.74203445 |
| 48 | Late onset (HP:0003584) | 2.72086481 |
| 49 | Heart block (HP:0012722) | 2.71828321 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.70423815 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.70423815 |
| 52 | Medial flaring of the eyebrow (HP:0010747) | 2.69855084 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.66052837 |
| 54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.66052837 |
| 55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.66052837 |
| 56 | Atrioventricular block (HP:0001678) | 2.65939157 |
| 57 | Fair hair (HP:0002286) | 2.64453076 |
| 58 | Inability to walk (HP:0002540) | 2.59129691 |
| 59 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.57048613 |
| 60 | Cerebellar dysplasia (HP:0007033) | 2.53964664 |
| 61 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.53062362 |
| 62 | Broad-based gait (HP:0002136) | 2.51556184 |
| 63 | Increased cerebral lipofuscin (HP:0011813) | 2.50414342 |
| 64 | Megalencephaly (HP:0001355) | 2.50209662 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.48264323 |
| 66 | Congenital hepatic fibrosis (HP:0002612) | 2.48111459 |
| 67 | Hyperglycemia (HP:0003074) | 2.47755100 |
| 68 | Febrile seizures (HP:0002373) | 2.45699820 |
| 69 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.44769387 |
| 70 | Abnormal atrioventricular conduction (HP:0005150) | 2.44726241 |
| 71 | Absent speech (HP:0001344) | 2.44302946 |
| 72 | Hemiplegia (HP:0002301) | 2.41059880 |
| 73 | Stomach cancer (HP:0012126) | 2.40333520 |
| 74 | Syncope (HP:0001279) | 2.40188155 |
| 75 | Hepatic necrosis (HP:0002605) | 2.40135994 |
| 76 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.39918175 |
| 77 | Metabolic alkalosis (HP:0200114) | 2.38255229 |
| 78 | Visual hallucinations (HP:0002367) | 2.37460814 |
| 79 | Prolonged QT interval (HP:0001657) | 2.36696184 |
| 80 | Abnormal ciliary motility (HP:0012262) | 2.36266298 |
| 81 | Limb hypertonia (HP:0002509) | 2.35931138 |
| 82 | Dysmetric saccades (HP:0000641) | 2.34665016 |
| 83 | Methylmalonic aciduria (HP:0012120) | 2.34262317 |
| 84 | Progressive inability to walk (HP:0002505) | 2.33929850 |
| 85 | Type II lissencephaly (HP:0007260) | 2.32257178 |
| 86 | Pheochromocytoma (HP:0002666) | 2.31527851 |
| 87 | Metabolic acidosis (HP:0001942) | 2.30856325 |
| 88 | Ventricular fibrillation (HP:0001663) | 2.29515540 |
| 89 | Dysostosis multiplex (HP:0000943) | 2.28976060 |
| 90 | Abnormality of alanine metabolism (HP:0010916) | 2.28848162 |
| 91 | Hyperalaninemia (HP:0003348) | 2.28848162 |
| 92 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.28848162 |
| 93 | Decreased central vision (HP:0007663) | 2.27988089 |
| 94 | Sudden death (HP:0001699) | 2.24963387 |
| 95 | Furrowed tongue (HP:0000221) | 2.23470764 |
| 96 | Hyperactive renin-angiotensin system (HP:0000841) | 2.23322764 |
| 97 | Polyuria (HP:0000103) | 2.22671023 |
| 98 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.22061584 |
| 99 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.21807522 |
| 100 | Action tremor (HP:0002345) | 2.21053629 |
| 101 | Decreased circulating renin level (HP:0003351) | 2.19702808 |
| 102 | Hypoalphalipoproteinemia (HP:0003233) | 2.19526589 |
| 103 | Facial diplegia (HP:0001349) | 2.19329532 |
| 104 | Tetraparesis (HP:0002273) | 2.17345419 |
| 105 | Xanthomatosis (HP:0000991) | 2.13651754 |
| 106 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.13057775 |
| 107 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.13057775 |
| 108 | Large for gestational age (HP:0001520) | 2.12997848 |
| 109 | Hyperkalemia (HP:0002153) | 2.11567665 |
| 110 | Postural instability (HP:0002172) | 2.10003999 |
| 111 | Athetosis (HP:0002305) | 2.09421815 |
| 112 | Generalized hypopigmentation of hair (HP:0011358) | 2.08819636 |
| 113 | Palpitations (HP:0001962) | 2.07627525 |
| 114 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.04715711 |
| 115 | Ventricular arrhythmia (HP:0004308) | 2.04429080 |
| 116 | Bile duct proliferation (HP:0001408) | 2.03876232 |
| 117 | Abnormal biliary tract physiology (HP:0012439) | 2.03876232 |
| 118 | Gait imbalance (HP:0002141) | 2.03839966 |
| 119 | Widely spaced teeth (HP:0000687) | 2.03696064 |
| 120 | Congenital primary aphakia (HP:0007707) | 2.03622771 |
| 121 | Abnormality of renin-angiotensin system (HP:0000847) | 2.03456660 |
| 122 | Anxiety (HP:0000739) | 2.02018877 |
| 123 | Amelogenesis imperfecta (HP:0000705) | 2.01975862 |
| 124 | Central scotoma (HP:0000603) | 2.01535577 |
| 125 | Abnormal EKG (HP:0003115) | 2.01481582 |
| 126 | Renal cortical cysts (HP:0000803) | 2.00453236 |
| 127 | Generalized tonic-clonic seizures (HP:0002069) | 1.99630488 |
| 128 | Asymmetric septal hypertrophy (HP:0001670) | 1.99342356 |
| 129 | Methylmalonic acidemia (HP:0002912) | 1.98586593 |
| 130 | Abnormal eating behavior (HP:0100738) | 1.96852967 |
| 131 | Bradycardia (HP:0001662) | 1.96412468 |
| 132 | Gout (HP:0001997) | 1.94337038 |
| 133 | Atrial fibrillation (HP:0005110) | 1.93873353 |
| 134 | Sensorimotor neuropathy (HP:0007141) | 1.93563267 |
| 135 | Status epilepticus (HP:0002133) | 1.93472329 |
| 136 | Sclerocornea (HP:0000647) | 1.93122135 |
| 137 | Hypoplastic ischia (HP:0003175) | 1.92893399 |
| 138 | Abnormality of potassium homeostasis (HP:0011042) | 1.92872318 |
| 139 | Anencephaly (HP:0002323) | 1.92836679 |
| 140 | Depression (HP:0000716) | 1.92376081 |
| 141 | Abnormality of the renal collecting system (HP:0004742) | 1.90829433 |
| 142 | Chorioretinal atrophy (HP:0000533) | 1.90552183 |
| 143 | Keratoconus (HP:0000563) | 1.90218664 |
| 144 | Increased corneal curvature (HP:0100692) | 1.90218664 |
| 145 | Hyperlipoproteinemia (HP:0010980) | 1.89726188 |
| 146 | Progressive cerebellar ataxia (HP:0002073) | 1.89656899 |
| 147 | Rhabdomyolysis (HP:0003201) | 1.89607766 |
| 148 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.88783044 |
| 149 | Focal seizures (HP:0007359) | 1.85400888 |
| 150 | Nephrogenic diabetes insipidus (HP:0009806) | 1.85183430 |
| 151 | Abnormal urine output (HP:0012590) | 1.84453452 |
| 152 | Patellar aplasia (HP:0006443) | 1.83902701 |
| 153 | Proximal tubulopathy (HP:0000114) | 1.82843799 |
| 154 | Abnormal social behavior (HP:0012433) | 1.81657634 |
| 155 | Impaired social interactions (HP:0000735) | 1.81657634 |
| 156 | Tubulointerstitial nephritis (HP:0001970) | 1.81073049 |
| 157 | Diplopia (HP:0000651) | 1.80630386 |
| 158 | Abnormality of binocular vision (HP:0011514) | 1.80630386 |
| 159 | Enlarged kidneys (HP:0000105) | 1.79566530 |
| 160 | Confusion (HP:0001289) | 1.79140607 |
| 161 | Epileptic encephalopathy (HP:0200134) | 1.78344812 |
| 162 | Abnormality of purine metabolism (HP:0004352) | 1.78286187 |
| 163 | Tachypnea (HP:0002789) | 1.78252812 |
| 164 | Hypoplasia of the pons (HP:0012110) | 1.78207841 |
| 165 | Supranuclear gaze palsy (HP:0000605) | 1.77947987 |
| 166 | Dysdiadochokinesis (HP:0002075) | 1.77619524 |
| 167 | Poor coordination (HP:0002370) | 1.77608238 |
| 168 | Delayed CNS myelination (HP:0002188) | 1.77033708 |
| 169 | Male pseudohermaphroditism (HP:0000037) | 1.76780655 |
| 170 | Hyperaldosteronism (HP:0000859) | 1.75658268 |
| 171 | Lethargy (HP:0001254) | 1.75140606 |
| 172 | Hypokalemia (HP:0002900) | 1.74814196 |
| 173 | Genital tract atresia (HP:0001827) | 1.74662116 |
| 174 | Genetic anticipation (HP:0003743) | 1.74559095 |
| 175 | Primary atrial arrhythmia (HP:0001692) | 1.73976913 |
| 176 | Bulbous nose (HP:0000414) | 1.73794006 |
| 177 | Ileus (HP:0002595) | 1.73733685 |
| 178 | Macular degeneration (HP:0000608) | 1.73368113 |
| 179 | Conjugated hyperbilirubinemia (HP:0002908) | 1.73247397 |
| 180 | Neuroendocrine neoplasm (HP:0100634) | 1.72689582 |
| 181 | Left ventricular hypertrophy (HP:0001712) | 1.72557543 |
| 182 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.72418804 |
| 183 | Increased muscle lipid content (HP:0009058) | 1.72315717 |
| 184 | Abnormal glucose tolerance (HP:0001952) | 1.71902406 |
| 185 | Dialeptic seizures (HP:0011146) | 1.71591523 |
| 186 | Abnormality of the pons (HP:0007361) | 1.71398198 |
| 187 | Tubulointerstitial abnormality (HP:0001969) | 1.70820808 |
| 188 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.70800615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 4.77196914 |
| 2 | LMTK2 | 3.67375128 |
| 3 | INSRR | 3.67327241 |
| 4 | BMPR1B | 3.63632619 |
| 5 | TRIB3 | 3.05244638 |
| 6 | SIK1 | 2.85663668 |
| 7 | ADRBK2 | 2.68175232 |
| 8 | NTRK3 | 2.65750657 |
| 9 | BCKDK | 2.63118408 |
| 10 | PRKD3 | 2.46168369 |
| 11 | NTRK2 | 2.21864378 |
| 12 | IRAK3 | 2.19449332 |
| 13 | EPHA4 | 2.16115775 |
| 14 | PHKG1 | 2.06278334 |
| 15 | PHKG2 | 2.06278334 |
| 16 | GRK1 | 1.96548796 |
| 17 | AKT3 | 1.93031996 |
| 18 | OBSCN | 1.86305811 |
| 19 | ZAK | 1.85640949 |
| 20 | PINK1 | 1.85556709 |
| 21 | CAMK1D | 1.85527250 |
| 22 | TNIK | 1.83185786 |
| 23 | PDK4 | 1.75295013 |
| 24 | PDK3 | 1.75295013 |
| 25 | SGK3 | 1.73326029 |
| 26 | OXSR1 | 1.71789311 |
| 27 | NUAK1 | 1.70853977 |
| 28 | TLK1 | 1.69906975 |
| 29 | SGK2 | 1.68804295 |
| 30 | STK39 | 1.62566673 |
| 31 | CAMK1G | 1.57460450 |
| 32 | RIPK1 | 1.51715979 |
| 33 | ERN1 | 1.51204023 |
| 34 | CAMKK2 | 1.49357518 |
| 35 | FRK | 1.46681615 |
| 36 | STK38 | 1.44584843 |
| 37 | MUSK | 1.40662353 |
| 38 | CAMKK1 | 1.38100175 |
| 39 | MAP4K2 | 1.36798407 |
| 40 | WNK3 | 1.32411382 |
| 41 | MAP3K2 | 1.31857090 |
| 42 | TGFBR1 | 1.31652097 |
| 43 | PIK3CG | 1.26399683 |
| 44 | SGK494 | 1.25988826 |
| 45 | SGK223 | 1.25988826 |
| 46 | SIK2 | 1.24771134 |
| 47 | PDPK1 | 1.23028081 |
| 48 | TIE1 | 1.22595856 |
| 49 | ADRBK1 | 1.22071774 |
| 50 | TAOK3 | 1.19719240 |
| 51 | MAP2K6 | 1.16102416 |
| 52 | MKNK2 | 1.15323497 |
| 53 | STK38L | 1.13888678 |
| 54 | PRKCH | 1.11220724 |
| 55 | MAP2K7 | 1.10226020 |
| 56 | CDC42BPA | 1.09932133 |
| 57 | PDK1 | 1.08234753 |
| 58 | TXK | 1.08053799 |
| 59 | NTRK1 | 1.05789110 |
| 60 | PRKAA2 | 1.03467798 |
| 61 | PDGFRA | 1.02540589 |
| 62 | MAP3K4 | 1.01666151 |
| 63 | PRKAA1 | 0.97432141 |
| 64 | DAPK2 | 0.95777503 |
| 65 | PDK2 | 0.94351210 |
| 66 | PAK6 | 0.94278039 |
| 67 | NLK | 0.93442502 |
| 68 | CAMK1 | 0.92144897 |
| 69 | MAP2K4 | 0.90721167 |
| 70 | TRPM7 | 0.89914342 |
| 71 | CDK5 | 0.89479908 |
| 72 | TEC | 0.88820408 |
| 73 | MAPKAPK3 | 0.86903055 |
| 74 | CASK | 0.86594992 |
| 75 | JAK1 | 0.83828823 |
| 76 | FGFR4 | 0.83643679 |
| 77 | LATS1 | 0.82633057 |
| 78 | MELK | 0.82494344 |
| 79 | WNK1 | 0.82384577 |
| 80 | FER | 0.80602759 |
| 81 | PTK2B | 0.80558036 |
| 82 | MAPK15 | 0.80492519 |
| 83 | IRAK2 | 0.79907405 |
| 84 | MAP3K7 | 0.79753961 |
| 85 | PTK6 | 0.75005824 |
| 86 | WNK4 | 0.74078885 |
| 87 | HIPK2 | 0.73146841 |
| 88 | PIK3CA | 0.72105381 |
| 89 | FGFR3 | 0.71489864 |
| 90 | MAP2K2 | 0.71118090 |
| 91 | KIT | 0.68795252 |
| 92 | PRKACG | 0.68161081 |
| 93 | RIPK4 | 0.66080764 |
| 94 | NEK1 | 0.65613782 |
| 95 | CAMK4 | 0.65480377 |
| 96 | SIK3 | 0.64248361 |
| 97 | SGK1 | 0.63632201 |
| 98 | PRKD1 | 0.63496098 |
| 99 | FGFR2 | 0.61987474 |
| 100 | MAP3K1 | 0.61218299 |
| 101 | RET | 0.61208061 |
| 102 | IKBKB | 0.61063300 |
| 103 | CHUK | 0.59806446 |
| 104 | MAP3K9 | 0.59284113 |
| 105 | ITK | 0.58843810 |
| 106 | MAPK11 | 0.58339341 |
| 107 | MINK1 | 0.56863305 |
| 108 | MAP3K13 | 0.54749185 |
| 109 | PRKD2 | 0.54736892 |
| 110 | PKN2 | 0.54490643 |
| 111 | JAK2 | 0.53260780 |
| 112 | GRK7 | 0.53094513 |
| 113 | PRKG2 | 0.53024775 |
| 114 | MAPK12 | 0.51193376 |
| 115 | PRKCE | 0.51106657 |
| 116 | DMPK | 0.50586865 |
| 117 | CAMK2A | 0.47850660 |
| 118 | IRAK1 | 0.46466345 |
| 119 | RPS6KA3 | 0.46291790 |
| 120 | PRKCQ | 0.45397774 |
| 121 | NEK6 | 0.44655199 |
| 122 | MYLK | 0.44605917 |
| 123 | STK3 | 0.44259041 |
| 124 | EPHA3 | 0.43385226 |
| 125 | BRSK2 | 0.43061601 |
| 126 | BRAF | 0.43004155 |
| 127 | MARK2 | 0.42954320 |
| 128 | FES | 0.42504414 |
| 129 | MARK3 | 0.42250527 |
| 130 | CAMK2D | 0.42168031 |
| 131 | PAK3 | 0.41837558 |
| 132 | PKN1 | 0.41435301 |
| 133 | BLK | 0.41290299 |
| 134 | PRKCG | 0.41050549 |
| 135 | JAK3 | 0.40704511 |
| 136 | SYK | 0.40242147 |
| 137 | CAMK2G | 0.40235122 |
| 138 | MAPK13 | 0.39376053 |
| 139 | ERBB2 | 0.38951535 |
| 140 | STK11 | 0.38732740 |
| 141 | MAP2K1 | 0.38530145 |
| 142 | PRPF4B | 0.37569674 |
| 143 | RPS6KA6 | 0.36957202 |
| 144 | PRKACA | 0.36358191 |
| 145 | TNK2 | 0.35421425 |
| 146 | FLT3 | 0.35221321 |
| 147 | TGFBR2 | 0.34868440 |
| 148 | MAPKAPK5 | 0.33802623 |
| 149 | MST4 | 0.33750011 |
| 150 | EIF2AK3 | 0.33508324 |
| 151 | PRKCA | 0.32249036 |
| 152 | RPS6KA5 | 0.31906488 |
| 153 | CSNK1A1 | 0.29853710 |
| 154 | PRKG1 | 0.28642648 |
| 155 | NME1 | 0.28318171 |
| 156 | CSNK1A1L | 0.27367114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.79379334 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.97297564 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.94151594 |
| 4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.75863605 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.67760803 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.57948722 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.57336994 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.40420044 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32956606 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 2.31700368 |
| 11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.24442826 |
| 12 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.20529508 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.18379883 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.01242333 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.92172899 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86448313 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.78691254 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76134208 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.75409315 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.75288613 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.74252451 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.63046882 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.62207761 |
| 24 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.60550827 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.60028619 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.42722279 |
| 27 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.42667632 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40538804 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.35767038 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.35511837 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.32465191 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.27261414 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.26935210 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.26816403 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26549726 |
| 36 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25949515 |
| 37 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.22900466 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21204044 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.19620674 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19303140 |
| 41 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.18192552 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15574941 |
| 43 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15268801 |
| 44 | Salivary secretion_Homo sapiens_hsa04970 | 1.13944865 |
| 45 | Nicotine addiction_Homo sapiens_hsa05033 | 1.12934421 |
| 46 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.11309835 |
| 47 | Homologous recombination_Homo sapiens_hsa03440 | 1.10981597 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.07582749 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.07232292 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07094748 |
| 51 | Circadian entrainment_Homo sapiens_hsa04713 | 1.07036213 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05888576 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 1.05385026 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05371382 |
| 55 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.03465367 |
| 56 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02829778 |
| 57 | Asthma_Homo sapiens_hsa05310 | 1.02646581 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.02524943 |
| 59 | Circadian rhythm_Homo sapiens_hsa04710 | 1.01815233 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.97606986 |
| 61 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.96882645 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95983637 |
| 63 | Morphine addiction_Homo sapiens_hsa05032 | 0.95329583 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94770932 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93387937 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.91020532 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89976021 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89488344 |
| 69 | Long-term potentiation_Homo sapiens_hsa04720 | 0.89100142 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.88012478 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.87986516 |
| 72 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87890600 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86282887 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85925269 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83454463 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83370536 |
| 77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82708430 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82476126 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.81525800 |
| 80 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.81489517 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.81260886 |
| 82 | Olfactory transduction_Homo sapiens_hsa04740 | 0.81154895 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.81115920 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80007701 |
| 85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79752164 |
| 86 | Taste transduction_Homo sapiens_hsa04742 | 0.79720312 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79644923 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78703531 |
| 89 | Cocaine addiction_Homo sapiens_hsa05030 | 0.77912656 |
| 90 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.77739609 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.77300552 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.74828585 |
| 93 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73538386 |
| 94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73377311 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71026842 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71009004 |
| 97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70913090 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70342718 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68541060 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68154398 |
| 101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67383838 |
| 102 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.63877268 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62355027 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60456599 |
| 105 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59568520 |
| 106 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56573391 |
| 107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55324285 |
| 108 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54583303 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53352059 |
| 110 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.53303350 |
| 111 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52922956 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51599238 |
| 113 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.48343370 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47471403 |
| 115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47079863 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46791953 |
| 117 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.46789257 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.46453037 |
| 119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.45845730 |
| 120 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.44341749 |
| 121 | Allograft rejection_Homo sapiens_hsa05330 | 0.44153913 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42776669 |
| 123 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41815688 |
| 124 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38756522 |
| 125 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38550257 |
| 126 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38323071 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38095182 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37242767 |
| 129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34361392 |
| 130 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34336763 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.33665676 |
| 132 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33494680 |
| 133 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33049009 |
| 134 | Basal transcription factors_Homo sapiens_hsa03022 | 0.32564588 |
| 135 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32449846 |
| 136 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32344443 |
| 137 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.32044400 |
| 138 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31677951 |
| 139 | Long-term depression_Homo sapiens_hsa04730 | 0.31013478 |
| 140 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30334385 |

